Boston Scientific Corporation
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $1.04B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $133.1M | 12.8% |
| Business Acquisitions | $4.8M | 0.5% |
| Other Investing | $2.8M | 0.3% |
| Other Financing | $550.4M | 52.9% |
| Working Capital | $106.0M | 10.2% |
| Other | $243.0M | 23.4% |
| Net Cash Flow | $0 | 0.0% |